Abstract
We read the interesting paper by Dr. Zaiss and colleagues ([1][1]) on the role of regulatory T cells (Treg cells) in local and systemic bone destruction in arthritis. We suggest that effective targeting of Treg cells makes CD28 superagonist Abs (CD28 SA) a promising novel reagent to prevent
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
